Stay updated on FT218 Efficacy in Narcolepsy: Clinical Trial
Sign up to get notified when there's something new on the FT218 Efficacy in Narcolepsy: Clinical Trial page.

Latest updates to the FT218 Efficacy in Narcolepsy: Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov record for the FT218 narcolepsy study is displayed, including its completed status, study design, eligibility criteria, outcomes, and locations. Previously, the page showed a 403 Forbidden error.SummaryDifference53%

- Check7 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice about the transition from “artificial intelligence” to “super intelligence” appears above the page, and the site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check35 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1; the study record page still displays a 403 error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access-denied message while the site header and footer remain visible.SummaryDifference0.5%

- Check49 days agoChange DetectedA broad set of related-term terms (MeSH keywords) and metadata fields, including data-sharing plan indicators and historical record dates, were removed from the study record page. This alters the visible taxonomy and record-history details but leaves the core study content and main results unchanged.SummaryDifference17%

Stay in the know with updates to FT218 Efficacy in Narcolepsy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT218 Efficacy in Narcolepsy: Clinical Trial page.